References |
1 |
Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. Curr Med Chem. 2009;16(31):4066-218.
|
2 |
Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology. 2003 Aug;144(8):3382-98.
|
3 |
DrugBank(Pharmacology-Metabolism)Estrone
|
4 |
Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett. 2005 Sep 28;227(2):115-24.
|
5 |
Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study. Breast Cancer Res. 2004;6(4):R352-65.
|
6 |
Dehydroepiandrosterone Research: Past, Current, and Future Vitam Horm. 2018;108:1-28. doi: 10.1016/bs.vh.2018.02.002.
|
7 |
DrugBank(Pharmacology-Metabolism):Estrone sulfate
|
8 |
DrugBank(Pharmacology-Metabolism)Estropipate
|
9 |
Resveratrol Inhibits Key Steps of Steroid Metabolism in a Human Estrogen-Receptor Positive Breast Cancer Model: Impact on Cellular Proliferation Front Pharmacol. 2018 Jul 10;9:742. doi: 10.3389/fphar.2018.00742.
|